These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 35610534)

  • 21. Inflammasomes, Autophagy, and Cell Death: The Trinity of Innate Host Defense against Intracellular Bacteria.
    Krakauer T
    Mediators Inflamm; 2019; 2019():2471215. PubMed ID: 30728749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inflammasomes in viral infection].
    Ichinohe T; Iwasaki A
    Uirusu; 2009 Jun; 59(1):13-21. PubMed ID: 19927984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular acidosis is a novel danger signal alerting innate immunity via the NLRP3 inflammasome.
    Rajamäki K; Nordström T; Nurmi K; Åkerman KE; Kovanen PT; Öörni K; Eklund KK
    J Biol Chem; 2013 May; 288(19):13410-9. PubMed ID: 23530046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammasomes in neuroinflammatory and neurodegenerative diseases.
    Voet S; Srinivasan S; Lamkanfi M; van Loo G
    EMBO Mol Med; 2019 Jun; 11(6):. PubMed ID: 31015277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The inflammasomes: platforms of innate immunity].
    Jamilloux Y; Henry T
    Med Sci (Paris); 2013 Nov; 29(11):975-84. PubMed ID: 24280500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evasion of inflammasome activation by microbial pathogens.
    Ulland TK; Ferguson PJ; Sutterwala FS
    J Clin Invest; 2015 Feb; 125(2):469-77. PubMed ID: 25642707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of innate and adaptive immunity by the inflammasome.
    Ciraci C; Janczy JR; Sutterwala FS; Cassel SL
    Microbes Infect; 2012 Nov; 14(14):1263-70. PubMed ID: 22841804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of inflammasome-derived IL-1 in driving IL-17 responses.
    Mills KH; Dungan LS; Jones SA; Harris J
    J Leukoc Biol; 2013 Apr; 93(4):489-97. PubMed ID: 23271701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensing damage by the NLRP3 inflammasome.
    Leemans JC; Cassel SL; Sutterwala FS
    Immunol Rev; 2011 Sep; 243(1):152-62. PubMed ID: 21884174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammasomes in the lung.
    Pinkerton JW; Kim RY; Robertson AAB; Hirota JA; Wood LG; Knight DA; Cooper MA; O'Neill LAJ; Horvat JC; Hansbro PM
    Mol Immunol; 2017 Jun; 86():44-55. PubMed ID: 28129896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-18 triggered by the Nlrp3 inflammasome induces host innate resistance in a pulmonary model of fungal infection.
    Ketelut-Carneiro N; Silva GK; Rocha FA; Milanezi CM; Cavalcanti-Neto FF; Zamboni DS; Silva JS
    J Immunol; 2015 May; 194(9):4507-17. PubMed ID: 25825440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammasome Antagonism by Human Parainfluenza Virus Type 3 C Protein.
    Shil NK; Pokharel SM; Banerjee AK; Hoffman M; Bose S
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29187536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of adaptive immunity by the NLRP3 inflammasome.
    Chen M; Wang H; Chen W; Meng G
    Int Immunopharmacol; 2011 May; 11(5):549-54. PubMed ID: 21118671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-1 Beta-A Friend or Foe in Malignancies?
    Bent R; Moll L; Grabbe S; Bros M
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammasome in Dendritic Cells Immunobiology: Implications to Diseases and Therapeutic Strategies.
    Ferreira I; Liberal J; Martins JD; Silva A; Neves BM; Cruz MT
    Curr Drug Targets; 2017; 18(9):1003-1018. PubMed ID: 27660056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyroptosis: The missing puzzle among innate and adaptive immunity crosstalk.
    Hachim MY; Khalil BA; Elemam NM; Maghazachi AA
    J Leukoc Biol; 2020 Jul; 108(1):323-338. PubMed ID: 32083338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The inflammasome in biomaterial-driven immunomodulation.
    Vasconcelos DP; Águas AP; Barbosa JN
    J Tissue Eng Regen Med; 2022 Dec; 16(12):1109-1120. PubMed ID: 36327091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the Inflammasome in Human Kupffer Cells in Response to Synthetic Agonists and Pathogens.
    Zannetti C; Roblot G; Charrier E; Ainouze M; Tout I; Briat F; Isorce N; Faure-Dupuy S; Michelet M; Marotel M; Kati S; Schulz TF; Rivoire M; Traverse-Glehen A; Luangsay S; Alatiff O; Henry T; Walzer T; Durantel D; Hasan U
    J Immunol; 2016 Jul; 197(1):356-67. PubMed ID: 27226092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COPs and POPs Patrol Inflammasome Activation.
    Indramohan M; Stehlik C; Dorfleutner A
    J Mol Biol; 2018 Jan; 430(2):153-173. PubMed ID: 29024695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review.
    Shin JI; Lee KH; Joo YH; Lee JM; Jeon J; Jung HJ; Shin M; Cho S; Kim TH; Park S; Jeon BY; Jeong H; Lee K; Kang K; Oh M; Lee H; Lee S; Kwon Y; Oh GH; Kronbichler A
    J Autoimmun; 2019 Sep; 103():102299. PubMed ID: 31326231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.